Agenus (AGEN) Reports Q4 Loss of $0.20/sh

Go back to Agenus (AGEN) Reports Q4 Loss of $0.20/sh

Agenus Inc. (AGEN) PT Lowered to $7 at Jefferies

March 16, 2021 7:56 AM EDT

Jefferies analyst Biren Amin lowered the price target on Agenus Inc. (NASDAQ: AGEN) to $7.00 (from $8.00) while maintaining a Buy rating.

The analyst commented, "On the Q4 call, mgmt stated that the BLA submission of balstilimab is on track to... More